Endologix Inc. (ELGX) Reports Q1 Loss of 9c, Misses by 3c; Reaffirms FY11 Guidance
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Total operating expenses: 48.17M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Total operating expenses: 48.17M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Endologix Inc. (NASDAQ: ELGX) reported Q1 EPS of ($0.09), $0.03 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $18.35 million.
Reaffirms FY outlook.
Reaffirms FY outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Tenon Medical (TNON) Misses Q2 EPS by 395c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
